NYSE$OHI

Omega Healthcare Investors Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Omega Healthcare reported a net loss for Q3 2020, but showed strength in AFFO and FAD, along with excellent rent collections and a lower dividend payout ratio.

Omega Healthcare Investors reported a net loss of ($93.8) million, or ($0.40) per common share, for the quarter ended September 30, 2020. However, the company's Adjusted Funds From Operations (AFFO) stood at $191.8 million, or $0.82 per common share, showing operational strength. Revenue for the quarter was $119.2 million.

  • Collected over 99% of third quarter contractual rent and mortgage payments (when excluding Daybreak).
  • Sold 6 facilities and a land parcel for $61 million in cash, recognizing a loss of $0.7 million.
  • Invested $22 million in capital renovation and construction-in-progress projects.
  • Issued $700 million aggregate principal amount of 3.375% Senior Notes due 2031 in October.

Headline financials

Total Revenue

$119M

Previous: $233M-48.9%
EPS (adj)

$0.82

Previous: $0.76+7.9%
Capital Expenditures

-$138M

Previous: -$191M+27.6%
Free Cash Flow

-$232M

Previous: -$48.1M-382.3%
Net Income

-$93.8M

Previous: $143M-165.6%
Operating Income

-$39.5M

Previous: $187M-121.1%
Gross Profit

$57.4M

Previous: $227M-74.7%
Cash & Equivalents

$36M

Previous: $40.9M-12.0%
Total Assets

$9.4B

Previous: $9B+4.5%
Stock-Based Comp

$5.12M

Previous: $2.92M+75.4%

Revenue & EPS history

Omega Healthcare · Revenue · Quarterly

$119M

Q3 2020-48.9%vs Q3 2019
Beat estimate in 6 of 16 quarters(38%)
ActualEstimate

Revenue by segment

Omega Healthcare · $31.8M total across 3 segments · Q3 2023

  • Real estate loans interest income
    $24.9M
  • Non-real estate loans interest income
    $5.73M
  • Miscellaneous income
    $1.21M+398.8%

Forward guidance

Due to the uncertainty related to the COVID-19 pandemic, the company has withdrawn its 2020 earnings guidance.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-0.1%

Avg return

Earnings day

+0.2%

Avg return

5 days after

+2.4%

Avg return

30 days after

49%

33 / 68 earnings

Positive

+13.1%

Q1 2022

Best reaction

-9.1%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.0%-2.6%-1.3%
Q4 2025+6.1%+5.8%+11.0%
Q3 2025+5.3%+7.9%+15.2%
Q1 2025-4.1%-7.5%-4.0%
Q4 2024-0.7%-6.0%-3.7%
Q3 2024+1.4%-4.5%-3.0%
Q2 2024+5.1%+1.8%+8.6%
Q1 2024+2.1%+0.8%+5.3%
Q4 2023+6.9%+10.2%+9.9%
Q3 2023-5.2%-5.8%-3.4%
Q2 2023-1.1%+1.0%+3.2%
Q1 2023+8.5%+7.9%+10.4%
Q4 2022-2.2%-5.1%-7.9%
Q3 2022-1.3%+2.5%-5.1%
Q2 2022+1.8%+3.2%+5.4%
Q1 2022+13.1%+11.3%+15.9%
Q4 2021-8.4%-11.2%-8.7%
Q3 2021+0.2%-4.7%-7.6%
Q2 2021-4.6%-3.2%-6.9%
Q1 2021-2.0%-3.9%-0.1%
Q4 2020-0.6%-1.2%+1.2%
Q3 2020-1.1%+3.8%+23.1%
Q2 2020+3.0%+4.8%-0.2%
Q1 2020+0.0%+1.8%+21.9%
Q4 2019-0.0%+1.4%-7.7%
Q3 2019-2.2%-5.4%-2.6%
Q2 2019+1.5%+7.8%+15.4%
Q1 2019+1.5%+4.3%+2.3%
Q4 2018-5.9%-6.9%-6.5%
Q3 2018+5.2%+7.5%+15.6%
Q2 2018+3.7%+5.5%+10.9%
Q1 2018+3.4%+7.0%+13.1%
Q4 2017-2.9%+1.4%+3.7%
Q3 2017-9.1%-10.6%-15.6%
Q2 2017-3.4%-4.9%-5.8%
Q1 2017-2.6%-0.8%-3.3%
Q4 2016-5.0%-1.8%-3.7%
Q3 2016-1.7%-6.5%-5.8%
Q2 2016+1.5%+1.9%+3.5%
Q1 2016-1.2%
Q4 2015+4.4%
Q3 2015-0.5%
Q2 2015+1.2%
Q1 2015-3.5%
Q4 2014-0.7%
Q3 2014+1.8%
Q2 2014+0.1%
Q1 2014-0.6%
Q4 2013-1.4%
Q3 2013-2.0%
Q2 2013-7.3%
Q1 2013+0.5%
Q4 2012+4.2%
Q3 2012-3.0%
Q2 2012+1.1%
Q1 2012+0.4%
Q4 2011-1.8%
Q3 2011+2.2%
Q2 2011+3.2%
Q1 2010+0.1%
Q1 2011+1.3%
Q4 2008-2.2%
Q4 2010-2.2%
Q3 2010-4.4%
Q3 2009-4.4%
Q2 2009+1.3%
Q2 2010+1.3%
Q4 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro